Acer Therapeutics Announces Administration of ACER-001 in a Fasted State Increased Systemic Exposure of Phenylbutyrate in Healthy Volunteer Food Effect Study

• NASDAQ: $ACER
• Notified: $3.50
• 16:01 EDT